At the molecular level, RA could suppress proinflammatory cytokines and inflammatory mediators by inhibiting the NF-kB/STAT3 signaling pathway, which has been confirmed by the use of commercial RA in colitis mice [34]. The gene discussed is STAT3; the disease is colitis.